Drug Profile
Selegiline orally disintegrating tablet - FP Pharmaceutical
Alternative Names: Efupi; FPF 1100 NWLatest Information Update: 03 Jun 2016
Price :
$50
*
At a glance
- Originator FP Pharmaceutical Corp
- Class Antiparkinsonians; Phenethylamines
- Mechanism of Action Monoamine oxidase B inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Parkinson's disease
Most Recent Events
- 03 Jun 2016 Chemical information added